0000874015-21-000085.txt : 20210617
0000874015-21-000085.hdr.sgml : 20210617
20210617170501
ACCESSION NUMBER: 0000874015-21-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUTO FREDERICK T
CENTRAL INDEX KEY: 0001181560
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 211025619
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-06-15
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001181560
MUTO FREDERICK T
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
Common Stock
2021-06-15
2021-06-15
4
M
0
5000
9.3
A
36683
D
Common Stock
2021-06-15
2021-06-15
4
S
0
5000
36.5
D
31683
D
Common Stock
2021-06-15
2021-06-15
4
M
0
5000
9.3
A
36683
D
Common Stock
2021-06-15
2021-06-15
4
S
0
5000
36.55
D
31683
D
Common Stock
2021-06-15
2021-06-15
4
M
0
5000
9.3
A
36683
D
Common Stock
2021-06-15
2021-06-15
4
S
0
5000
36.85
D
31683
D
Non-Qualified Stock Option (right to buy)
9.3
2021-06-15
2021-06-15
4
M
0
5000
0.0
D
2012-07-01
2021-06-30
Common Stock
5000
10000
D
Non-Qualified Stock Option (right to buy)
9.3
2021-06-15
2021-06-15
4
M
0
5000
0.0
D
2012-07-01
2021-06-30
Common Stock
5000
5000
D
Non-Qualified Stock Option (right to buy)
9.3
2021-06-15
2021-06-15
4
M
0
5000
0.0
D
2012-07-01
2021-06-30
Common Stock
5000
0
D
Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
By: Patrick R. O'Neil, attorney-in-fact For: Frederick T. Muto
2021-06-16